[HTML][HTML] Pulmonary fibrosis: pathogenesis, etiology and regulation
MS Wilson, TA Wynn - Mucosal immunology, 2009 - Elsevier
Pulmonary fibrosis and architectural remodeling of tissues can severely disrupt lung
function, often with fatal consequences. The etiology of pulmonary fibrotic diseases is varied …
function, often with fatal consequences. The etiology of pulmonary fibrotic diseases is varied …
Sarcoidosis: causes, diagnosis, clinical features, and treatments
Sarcoidosis is a multisystem granulomatous disease with nonspecific clinical manifestations
that commonly affects the pulmonary system and other organs including the eyes, skin, liver …
that commonly affects the pulmonary system and other organs including the eyes, skin, liver …
Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions
Diagnosis in psychiatry increasingly struggles to fulfil its key purposes, namely, to guide
treatment and to predict outcome. The clinical staging model, widely used in clinical …
treatment and to predict outcome. The clinical staging model, widely used in clinical …
Alternatively activated alveolar macrophages in pulmonary fibrosis—mediator production and intracellular signal transduction
DV Pechkovsky, A Prasse, F Kollert, KMY Engel… - Clinical …, 2010 - Elsevier
Activated macrophages have been characterized as M1 and M2 according to their
inflammatory response pattern. Here we analyzed the M2 marker expression and …
inflammatory response pattern. Here we analyzed the M2 marker expression and …
Sarcoidosis: clinical update
U Costabel - European respiratory journal, 2001 - Eur Respiratory Soc
Many advances have been made regarding sarcoidosis in the past 2 decades. As a result,
sarcoidosis is now defined as a multisystem disorder with a heightened cellular immune …
sarcoidosis is now defined as a multisystem disorder with a heightened cellular immune …
Clinical staging: a heuristic model for psychiatry and youth mental health
Diagnosis in psychiatry continues to struggle to fulfil its key purposes, namely to guide
treatment and to predict outcome. A clinical staging model, widely used in clinical medicine …
treatment and to predict outcome. A clinical staging model, widely used in clinical medicine …
Particulate matter induces cytokine expression in human bronchial epithelial cells
T Fujii, S Hayashi, JC Hogg, R Vincent… - American journal of …, 2001 - atsjournals.org
The present study was designed to determine cytokines produced by primary human
bronchial epithelial cells (HBECs) exposed to ambient air pollution particles (EHC-93) …
bronchial epithelial cells (HBECs) exposed to ambient air pollution particles (EHC-93) …
Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen
J Muller-Quernheim, K Kienast, M Held… - European …, 1999 - Eur Respiratory Soc
In a few patients with chronic sarcoidosis, prolonged, unacceptably high doses of
corticosteroids are required to achieve symptomatic relief. In these cases, a corticosteroid …
corticosteroids are required to achieve symptomatic relief. In these cases, a corticosteroid …
Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis
MW Ziegenhagen, ME Rothe, M Schlaak… - European …, 2003 - Eur Respiratory Soc
The aim of the present study was to determine which bronchoalveolar lavage fluid (BALF)
and serological parameters reflect the severity of newly diagnosed pulmonary sarcoidosis …
and serological parameters reflect the severity of newly diagnosed pulmonary sarcoidosis …
Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses
MT Miller, K Stromland - 1999 - pesquisa.bvsalud.org
Teratogen update: thalidomide: a review, with a focus on ocular findings and new potential
uses | sl; sn; 1999. 16 p. ilus, tab. | SES-SP | HANSEN | HANSENIASE | SESSP-ILSLACERVO …
uses | sl; sn; 1999. 16 p. ilus, tab. | SES-SP | HANSEN | HANSENIASE | SESSP-ILSLACERVO …